1q9m
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1q9m.jpg|left|200px]] | [[Image:1q9m.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1q9m", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_1q9m| PDB=1q9m | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity''' | '''Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity''' | ||
Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 1Q9M is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry | + | 1Q9M is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=1oym 1oym]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Q9M OCA]. |
==Reference== | ==Reference== | ||
Line 32: | Line 29: | ||
[[Category: Sun, Y.]] | [[Category: Sun, Y.]] | ||
[[Category: Wang, H.]] | [[Category: Wang, H.]] | ||
- | [[Category: | + | [[Category: Pde]] |
- | [[Category: | + | [[Category: Rolipram]] |
- | [[Category: | + | [[Category: Specific inhibitor]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:02:30 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 03:02, 3 May 2008
Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity
Overview
Selective inhibitors against the 11 families of cyclic nucleotide phosphodiesterases (PDEs) are used to treat various human diseases. How the inhibitors selectively bind the conserved PDE catalytic domains is unknown. The crystal structures of the PDE4D2 catalytic domain in complex with (R)- or (R,S)-rolipram suggest that inhibitor selectivity is determined by the chemical nature of amino acids and subtle conformational changes of the binding pockets. The conformational states of Gln369 in PDE4D2 may play a key role in inhibitor recognition. The corresponding Y329S mutation in PDE7 may lead to loss of the hydrogen bonds between rolipram and Gln369 and is thus a possible reason explaining PDE7's insensitivity to rolipram inhibition. Docking of the PDE5 inhibitor sildenafil into the PDE4 catalytic pocket further helps understand inhibitor selectivity.
About this Structure
1Q9M is a Single protein structure of sequence from Homo sapiens. This structure supersedes the now removed PDB entry 1oym. Full crystallographic information is available from OCA.
Reference
Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity., Huai Q, Wang H, Sun Y, Kim HY, Liu Y, Ke H, Structure. 2003 Jul;11(7):865-73. PMID:12842049 Page seeded by OCA on Sat May 3 06:02:30 2008